Kolexia
Mac Grogan Gaetan Anatomie et cytologie
Mac Grogan Gaetan
Anatomie et cytologie
Institut Bergonié
Bordeaux, France
163 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes Tumeurs du sein triple-négatives Récidive tumorale locale Métastase lymphatique Carcinome canalaire du sein Métastase tumorale Carcinome lobulaire Maladie résiduelle

Collaborateurs

Voir plus
Bonnefoi Herve
Bonnefoi Herve
Institut Bergonié, Bordeaux, France
Debled Marc
Debled Marc
Institut Bergonié, Bordeaux, France
Arnould Laurent
Arnould Laurent
Centre Georges-François Leclerc, Dijon, France
Mathoulin-Pelissier Simone
Mathoulin-Pelissier Simone
Institut Bergonié, Bordeaux, France

Industries

Voir plus
MSD
11 collaboration(s)
Dernière en 2023
AstraZeneca
11 collaboration(s)
Dernière en 2023
Gilead
9 collaboration(s)
Dernière en 2023
Roche
5 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life data.
Breast (Edinburgh, Scotland)   22 décembre 2023
309P Machine learning-based characterization of tumor-immune microenvironment at a spatial and multiplexed resolution in early breast cancer: A sub-study of the EORTC 10994/BIG 1-00 randomized phase III trial with long-term follow-up
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Development of Radiopharmaceuticals for NPY Receptor-5 (Y5) Nuclear Imaging in Tumors by Synthesis of Specific Agonists and Investigation of Their Binding Mode.
Bioconjugate chemistry   09 août 2023
Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers.
Computer methods and programs in biomedicine   03 février 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Annals of oncology : official journal of the European Society for Medical Oncology   25 janvier 2023
213MO Primary endpoint analysis of a randomized phase II of darolutamide or capecitabine in patients with triple-negative androgen receptor-positive advanced breast cancer (UCBG3-06 START trial)
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy.
ESMO open   24 juin 2022
8P An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
Abstract Book of ESMO Breast Cancer 2022, Berlin, Germany, 03-05 May 2022   01 mai 2022
Neoadjuvant chemotherapy and radiotherapy for locally advanced breast cancer: Safety and efficacy of reverse sequence compared to standard technique?
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   29 avril 2022
PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas.
Cancer genetics   25 février 2022